![Neil Bhowmick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 435 961 $ al 30/06/2026
Dr. Neil Bhowmick is a Chief Executive Officer at Enviro Therapeutics, Inc., a Chief Scientific Officer at Kairos Pharma Ltd., a Director-Cancer Biology Program at Cedars-Sinai Cancer Center and a Professor-Medicine at Cedars-Sinai Medical Center.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
KAIROS PHARMA, LTD. 5,3 % | 31/03/2026 | 1.135.316 ( 5,3 % ) | 435 961 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| KAIROS PHARMA, LTD. | Director Técnico/Científico/I+D | - |
Cedars-Sinai Cancer Center | Corporate Officer/Principal | - |
Cedars-Sinai Medical Center
 Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Health Services |
Cedars-Sinai Cancer Center | |
Kairos Pharma Ltd.
 Kairos Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
